Literature DB >> 22888142

Aspirin and cancer: trials and observational studies.

John A Baron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22888142     DOI： 10.1093/jnci/djs338

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

Review 1.  Polypharmacology: drug discovery for the future.

Authors:  A Srinivas Reddy; Shuxing Zhang
Journal:  Expert Rev Clin Pharmacol       Date:  2013-01       Impact factor: 5.045

2.  [Aspirin and prevention of colorectal carcinomas].

Authors:  K Schrör; B H Rauch
Journal:  Internist (Berl)       Date:  2013-07       Impact factor: 0.743

3.  Cancers prevented in Australia in 2010 through the consumption of aspirin.

Authors:  Louise F Wilson; Adele C Green; Bradley J Kendall; Susan J Jordan; Christina M Nagle; Christopher J Bain; Rachel E Neale; David C Whiteman
Journal:  Aust N Z J Public Health       Date:  2015-10       Impact factor: 2.939

4.  Aspirin use and risk of age-related macular degeneration: a meta-analysis.

Authors:  Wei Zhu; Yan Wu; Ding Xu; Yan-Hong Li; Ba Jun; Xiao-Long Zhang; Fang Wang; Jing Yu
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

5.  Endomicroscopic Imaging of COX-2 Activity in Murine Sporadic and Colitis-Associated Colorectal Cancer.

Authors:  Sebastian Foersch; Clemens Neufert; Markus F Neurath; Maximilian J Waldner
Journal:  Diagn Ther Endosc       Date:  2013-01-15

Review 6.  Cancer risk in immune-mediated inflammatory diseases (IMID).

Authors:  Rudi Beyaert; Laurent Beaugerie; Gert Van Assche; Lieve Brochez; Jean-Christophe Renauld; Manuelle Viguier; Veronique Cocquyt; Guy Jerusalem; Jean-Pascal Machiels; Hans Prenen; Pierre Masson; Edouard Louis; Filip De Keyser
Journal:  Mol Cancer       Date:  2013-08-29       Impact factor: 27.401
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.